Floatz logo

Bocidelpar

Healthy Volunteers

Astellas Pharma Global Development, Inc.Small moleculePhase 1Active
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

64 Active assets in the Healthy Volunteers cohort.

View all 50

Same molecule, other indications

Bocidelpar is also rated in:

liver disorderDormant
CC
Indicative ·
47 / 100
View asset →
Duchenne muscular dystrophyDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →